Study to Evaluate SYN115 in Parkinson's Disease

NCT00605553 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Placebo
DRUG: Tozadenant

Sponsor

Biotie Therapies Inc.